share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

诺瓦瓦克斯医药 | 4:持股变动声明-高管 Trizzino John
美股SEC公告 ·  08/21 16:50
Moomoo AI 已提取核心信息
On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
2024年8月19日,诺瓦瓦克斯医药公司(NVAX)的执行副总裁兼首席商业官John Trizzino完成了一笔涉及公司普通股的股票交易。Trizzino行使期权以无成本获得655股股票,随后以每股13.9美元的价格出售了317股。在这些交易之后,Trizzino在诺瓦瓦克斯医药公司的直接持股达到28,310股。出售股票的总市值为4,406.3美元。
2024年8月19日,诺瓦瓦克斯医药公司(NVAX)的执行副总裁兼首席商业官John Trizzino完成了一笔涉及公司普通股的股票交易。Trizzino行使期权以无成本获得655股股票,随后以每股13.9美元的价格出售了317股。在这些交易之后,Trizzino在诺瓦瓦克斯医药公司的直接持股达到28,310股。出售股票的总市值为4,406.3美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息